Global Equine Pharmaceuticals and Supplements Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Equine Pharmaceuticals and Supplements Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Type
  • 1.4.2 Pharmaceuticals
  • 1.4.3 Supplements
• 1.3 Market by Application
  • 1.3.1 Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Application
  • 1.3.2 Thoroughbred Horse
  • 1.3.3 Other Types of Horses
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Equine Pharmaceuticals and Supplements Sales Estimates and Forecasts 2016-2027
• 2.2 Global Equine Pharmaceuticals and Supplements Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Equine Pharmaceuticals and Supplements Regions by Sales
  • 2.4.1 Global Top Equine Pharmaceuticals and Supplements Regions by Sales (2016-2021)
  • 2.4.2 Global Top Equine Pharmaceuticals and Supplements Regions by Sales (2022-2027)
• 2.5 Global Top Equine Pharmaceuticals and Supplements Regions by Revenue
  • 2.5.1 Global Top Equine Pharmaceuticals and Supplements Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Equine Pharmaceuticals and Supplements Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Equine Pharmaceuticals and Supplements Sales by Manufacturers
  • 3.1.1 Global Top Equine Pharmaceuticals and Supplements Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Equine Pharmaceuticals and Supplements Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Equine Pharmaceuticals and Supplements Sales in 2020
• 3.2 Global Equine Pharmaceuticals and Supplements Revenue by Manufacturers
  • 3.2.1 Global Top Equine Pharmaceuticals and Supplements Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Equine Pharmaceuticals and Supplements Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Equine Pharmaceuticals and Supplements Revenue in 2020
• 3.3 Global Equine Pharmaceuticals and Supplements Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Equine Pharmaceuticals and Supplements Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Equine Pharmaceuticals and Supplements Sales by Type
  • 4.1.1 Global Equine Pharmaceuticals and Supplements Historical Sales by Type (2016-2021)
  • 4.1.2 Global Equine Pharmaceuticals and Supplements Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2027)
• 4.2 Global Equine Pharmaceuticals and Supplements Revenue by Type
  • 4.2.1 Global Equine Pharmaceuticals and Supplements Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Equine Pharmaceuticals and Supplements Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2016-2027)
• 4.3 Global Equine Pharmaceuticals and Supplements Price by Type
  • 4.3.1 Global Equine Pharmaceuticals and Supplements Price by Type (2016-2021)
  • 4.3.2 Global Equine Pharmaceuticals and Supplements Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Equine Pharmaceuticals and Supplements Sales by Application
  • 5.1.1 Global Equine Pharmaceuticals and Supplements Historical Sales by Application (2016-2021)
  • 5.1.2 Global Equine Pharmaceuticals and Supplements Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2027)
• 5.2 Global Equine Pharmaceuticals and Supplements Revenue by Application
  • 5.2.1 Global Equine Pharmaceuticals and Supplements Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Equine Pharmaceuticals and Supplements Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2016-2027)
• 5.3 Global Equine Pharmaceuticals and Supplements Price by Application
  • 5.3.1 Global Equine Pharmaceuticals and Supplements Price by Application (2016-2021)
  • 5.3.2 Global Equine Pharmaceuticals and Supplements Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Equine Pharmaceuticals and Supplements Market Size by Type
  • 6.1.1 North America Equine Pharmaceuticals and Supplements Sales by Type (2016-2027)
  • 6.1.2 North America Equine Pharmaceuticals and Supplements Revenue by Type (2016-2027)
• 6.2 North America Equine Pharmaceuticals and Supplements Market Size by Application
  • 6.2.1 North America Equine Pharmaceuticals and Supplements Sales by Application (2016-2027)
  • 6.2.2 North America Equine Pharmaceuticals and Supplements Revenue by Application (2016-2027)
• 6.3 North America Equine Pharmaceuticals and Supplements Market Size by Country
  • 6.3.1 North America Equine Pharmaceuticals and Supplements Sales by Country (2016-2027)
  • 6.3.2 North America Equine Pharmaceuticals and Supplements Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Equine Pharmaceuticals and Supplements Market Size by Type
  • 7.1.1 Europe Equine Pharmaceuticals and Supplements Sales by Type (2017-2027)
  • 7.1.2 Europe Equine Pharmaceuticals and Supplements Revenue by Type (2017-2027)
• 7.2 Europe Equine Pharmaceuticals and Supplements Market Size by Application
  • 7.2.1 Europe Equine Pharmaceuticals and Supplements Sales by Application (2017-2027)
  • 7.2.2 Europe Equine Pharmaceuticals and Supplements Revenue by Application (2017-2027)
• 7.3 Europe Equine Pharmaceuticals and Supplements Market Size by Country
  • 7.3.1 Europe Equine Pharmaceuticals and Supplements Sales by Country (2017-2027)
  • 7.3.2 Europe Equine Pharmaceuticals and Supplements Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Type
  • 8.1.1 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Type (2018-2027)
• 8.2 Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Application
  • 8.2.1 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Application (2018-2027)
• 8.3 Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Region
  • 8.3.1 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Equine Pharmaceuticals and Supplements Market Size by Type
  • 9.1.1 Latin America Equine Pharmaceuticals and Supplements Sales by Type (2019-2027)
  • 9.1.2 Latin America Equine Pharmaceuticals and Supplements Revenue by Type (2019-2027)
• 9.2 Latin America Equine Pharmaceuticals and Supplements Market Size by Application
  • 9.2.1 Latin America Equine Pharmaceuticals and Supplements Sales by Application (2019-2027)
  • 9.2.2 Latin America Equine Pharmaceuticals and Supplements Revenue by Application (2019-2027)
• 9.3 Latin America Equine Pharmaceuticals and Supplements Market Size by Country
  • 9.3.1 Latin America Equine Pharmaceuticals and Supplements Sales by Country (2019-2027)
  • 9.3.2 Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Type
  • 6.1.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Application
  • 6.2.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Country
  • 6.3.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 Boehringer Ingelheim
  • 11.1.1 Boehringer Ingelheim Corporation Information
  • 11.1.2 Boehringer Ingelheim Overview
  • 11.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Description
  • 11.1.5 Boehringer Ingelheim Related Developments
• 11.2 Merck Animal Health
  • 11.2.1 Merck Animal Health Corporation Information
  • 11.2.2 Merck Animal Health Overview
  • 11.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Product Description
  • 11.2.5 Merck Animal Health Related Developments
• 11.3 Zoetis
  • 11.3.1 Zoetis Corporation Information
  • 11.3.2 Zoetis Overview
  • 11.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Zoetis Equine Pharmaceuticals and Supplements Product Description
  • 11.3.5 Zoetis Related Developments
• 11.4 Bayer Animal Health
  • 11.4.1 Bayer Animal Health Corporation Information
  • 11.4.2 Bayer Animal Health Overview
  • 11.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Description
  • 11.4.5 Bayer Animal Health Related Developments
• 11.5 Elanco Animal Health
  • 11.5.1 Elanco Animal Health Corporation Information
  • 11.5.2 Elanco Animal Health Overview
  • 11.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Description
  • 11.5.5 Elanco Animal Health Related Developments
• 11.6 Dechra Veterinary Products
  • 11.6.1 Dechra Veterinary Products Corporation Information
  • 11.6.2 Dechra Veterinary Products Overview
  • 11.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Description
  • 11.6.5 Dechra Veterinary Products Related Developments
• 11.7 CEVA
  • 11.7.1 CEVA Corporation Information
  • 11.7.2 CEVA Overview
  • 11.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 CEVA Equine Pharmaceuticals and Supplements Product Description
  • 11.7.5 CEVA Related Developments
• 11.8 Virbac
  • 11.8.1 Virbac Corporation Information
  • 11.8.2 Virbac Overview
  • 11.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Virbac Equine Pharmaceuticals and Supplements Product Description
  • 11.8.5 Virbac Related Developments
• 11.9 Norbrook Equine
  • 11.9.1 Norbrook Equine Corporation Information
  • 11.9.2 Norbrook Equine Overview
  • 11.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Product Description
  • 11.9.5 Norbrook Equine Related Developments
• 11.10 Kyoritsu Seiyaku
  • 11.10.1 Kyoritsu Seiyaku Corporation Information
  • 11.10.2 Kyoritsu Seiyaku Overview
  • 11.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Description
  • 11.10.5 Kyoritsu Seiyaku Related Developments
• 11.1 Boehringer Ingelheim
  • 11.1.1 Boehringer Ingelheim Corporation Information
  • 11.1.2 Boehringer Ingelheim Overview
  • 11.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Description
  • 11.1.5 Boehringer Ingelheim Related Developments
• 11.12 Protexin Healthcare
  • 11.12.1 Protexin Healthcare Corporation Information
  • 11.12.2 Protexin Healthcare Overview
  • 11.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.12.4 Protexin Healthcare Product Description
  • 11.12.5 Protexin Healthcare Related Developments
• 11.13 Audevard
  • 11.13.1 Audevard Corporation Information
  • 11.13.2 Audevard Overview
  • 11.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.13.4 Audevard Product Description
  • 11.13.5 Audevard Related Developments
• 11.14 Ouro Fino Saude
  • 11.14.1 Ouro Fino Saude Corporation Information
  • 11.14.2 Ouro Fino Saude Overview
  • 11.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.14.4 Ouro Fino Saude Product Description
  • 11.14.5 Ouro Fino Saude Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Equine Pharmaceuticals and Supplements Value Chain Analysis
• 12.2 Equine Pharmaceuticals and Supplements Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Equine Pharmaceuticals and Supplements Production Mode & Process
• 12.4 Equine Pharmaceuticals and Supplements Sales and Marketing
  • 12.4.1 Equine Pharmaceuticals and Supplements Sales Channels
  • 12.4.2 Equine Pharmaceuticals and Supplements Distributors
• 12.5 Equine Pharmaceuticals and Supplements Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Equine Pharmaceuticals and Supplements Industry Trends
• 13.2 Equine Pharmaceuticals and Supplements Market Drivers
• 13.3 Equine Pharmaceuticals and Supplements Market Challenges
• 13.4 Equine Pharmaceuticals and Supplements Market Restraints

14 Key Findings in The Global Equine Pharmaceuticals and Supplements Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details